Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease

Abstract

The earliest event so far known that occurs in the brain affected with Alzheimer's disease (AD) is the deposition and fibril formation of amyloid β–protein (Aβ). Aβ is cleaved from a glycosylated membrane protein, called β–amyloid protein precursor, and normally secreted into the extracellular space. Here we report on the presence of membrane–bound Aβ that tightly binds CM1 ganglioside. This suggests that this novel Aβ species, rather than secreted Aβ, may act as a ‘seed’ for amyloid and further that intracellular abnormalities in the membrane recycling already exist at the stage of amyloidogenesis

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mullan, M. & Crawford, F. Genetic and molecular advances in Alzheimer's disease. Trends Neurosd. 16, 398–403 (1993).

    Article  CAS  Google Scholar 

  2. Selkoe, D.J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. CellBiol. 10, 373–403 (1994).

    Article  CAS  Google Scholar 

  3. Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736 (1987).

    Article  CAS  Google Scholar 

  4. Mori, H., Takio, K., Ogawara, M. & Selkoe, D.J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. biol. Chem. 267, 17082–17086 (1992).

    CAS  PubMed  Google Scholar 

  5. Roher, A.E. et al. Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. biol. Chem. 268, 3072–3083 (1993).

    CAS  PubMed  Google Scholar 

  6. Yamaguchi, H., Nakazato, Y., Hirai, S., Shoji, M. & Harigaya, Y. Electron micrograph of diffuse plaques: Initial stage of senile plaque formation in the Alzheimer brain. Am. J. Pathol 135, 593–597 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Davies, C.A. & Mann, D.M.A. Is the “preamyloid” of diffuse plaques in Alzheimer's disease really nonfibrillar? Am. J. Pathol. 143, 1594–1605 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Yamaguchi, H. et al. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β protein immunostaining. Ada Neuropathol. 76, 541–549 (1988).

    Article  CAS  Google Scholar 

  9. Yamaguchi, H., Nakazato, Y., Hirai, S. & Shoji, M. Immunoelectron microscopic localization of amyloid β protein in the diffuse plaques of the Alzheimer-type dementia. Brain Res. 508, 320–324 (1990).

    Article  CAS  Google Scholar 

  10. Yamazaki, T. et al. Ultrastructural characterization of cerebellar diffuse plaques in Alzheimer's disease. J. Neuropathol. exp. Neurol. 51, 281–286 (1992).

    Article  CAS  Google Scholar 

  11. Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP 717) mutants. Science 264, 1336–1340 (1994).

    Article  CAS  Google Scholar 

  12. Iwatsubo, T. et al. Visualization of Aβ42 (43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Ap42 (43). Neuron 13, 45–53 (1994).

    Article  CAS  Google Scholar 

  13. Mann, D.M.A. Cerebral amyloidosis, ageing and Alzheimer's disease: A contribution from studies on Down's syndrome. Neurobiol. Aging 10, 397–399 (1989).

    Article  CAS  Google Scholar 

  14. Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Prot. natn. Acad. Sci. U.S.A. 82, 4245–4249 (1985).

    Article  CAS  Google Scholar 

  15. Suzuki, N. et al. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452–460 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosd. Res. Commun. 2, 121–130 (1988).

    CAS  Google Scholar 

  17. Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325 (1992).

    Article  CAS  Google Scholar 

  18. Seubert, P. et al. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325–327 (1992).

    Article  CAS  Google Scholar 

  19. Shoji, M. et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126–129 (1992).

    Article  CAS  Google Scholar 

  20. Pike, C.J., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311–314 (1991).

    Article  CAS  Google Scholar 

  21. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).

    Article  CAS  Google Scholar 

  22. Pan, B.-T. & Johnstone, R.M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor. Cell 33, 967–977 (1983).

    Article  CAS  Google Scholar 

  23. Hansson, H.A., Holmgren, J. & Svennerholm, L. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc. natn. Acad. Sci. U.S.A. 74, 3782–3786 (1977).

    Article  CAS  Google Scholar 

  24. Parton, R.G. Ultrastructural localization of gangliosides: GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42, 155–166 (1994).

    Article  CAS  Google Scholar 

  25. Dupree, P. et al. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12, 1597–1605 (1993).

    Article  CAS  Google Scholar 

  26. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754–760 (1995).

    Article  CAS  Google Scholar 

  27. L'Hernault, S.W.L. & Arduengo, P.M. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J. Cell Biol. 119, 55–69 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yanagisawa, K., Odaka, A., Suzuki, N. et al. GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease. Nat Med 1, 1062–1066 (1995). https://doi.org/10.1038/nm1095-1062

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-1062

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing